Get the Stockscreener App
11.94
4.33%
-0.54
After Hours:
11.89
-0.05
-0.42%
Gh Research Plc stock is traded at $11.94, with a volume of 164.09K.
It is down -4.33% in the last 24 hours and down -1.65% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$12.48
Open:
$12.44
24h Volume:
164.09K
Relative Volume:
0.69
Market Cap:
$621.22M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-15.11
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
-15.26%
1M Performance:
-1.65%
6M Performance:
+5.20%
1Y Performance:
+41.13%
1-Day Range:
$11.83
$12.47
1-Week Range:
$11.83
$14.17
52-Week Range:
$6.00
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
11.94 | 799.56M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
Heatmap analysis for GH Research PLC and competitorsQuarterly Trade Report & Reliable Momentum Entry Alerts - Newser
Can trapped investors hope for a rebound in GH Research PLCTrade Risk Summary & Community Shared Stock Ideas - Newser
Institutional scanner results for GH Research PLCDip Buying & Long-Term Safe Investment Ideas - Newser
Momentum divergence signals in GH Research PLC chartQuarterly Growth Report & Capital Efficient Trading Techniques - Newser
Will GH Research PLC outperform the market2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
How to escape a deep drawdown in GH Research PLC2025 Year in Review & Scalable Portfolio Growth Ideas - Newser
Technical analysis overview for GH Research PLC stockWeekly Trend Report & Safe Capital Growth Plans - Newser
Advanced analytics toolkit walkthrough for GH Research PLCIPO Watch & Daily Profit Maximizing Tips - Newser
How to monitor GH Research PLC with trend dashboardsTreasury Yields & Community Verified Trade Alerts - Newser
GH Research to Join TD Cowen Neuropsychiatry Summit - TipRanks
Is a relief rally coming for GH Research PLC holdersJuly 2025 Trends & Risk Controlled Daily Trade Plans - Newser
GH Research Presents Promising Trial Results for GH001 at ISBD 2025 - MSN
Will GH Research PLC bounce back from current supportTrade Signal Summary & Risk Managed Investment Strategies - Newser
454,975 Shares in GH Research PLC $GHRS Acquired by Alyeska Investment Group L.P. - MarketBeat
When is the best time to exit GH Research PLCWeekly Market Outlook & Accurate Intraday Trade Tips - Newser
Using data filters to optimize entry into GH Research PLCMarket Sentiment Report & Low Risk Profit Maximizing Plans - Newser
Can GH Research PLC rally from current levelsQuarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
What MACD and RSI say about GH Research PLCPortfolio Performance Report & Daily Volume Surge Trade Alerts - Newser
Smart tools for monitoring GH Research PLC’s price actionJuly 2025 Setups & Expert Verified Stock Movement Alerts - Newser
How to build a dashboard for GH Research PLC stockPortfolio Gains Report & Verified High Yield Trade Plans - Newser
Cantor Fitzgerald reiterates Overweight rating on GH Research stock - Investing.com
should you wait for a breakout in gh research plc2025 Analyst Calls & Weekly High Return Forecasts - Newser
Trend analysis for GH Research PLC this weekJuly 2025 Rallies & Short-Term High Return Strategies - Newser
Cormorant Asset Management LP Increases Position in GH Research PLC $GHRS - MarketBeat
Is GH Research PLC stock bottoming outWeekly Stock Summary & Expert Curated Trade Setup Alerts - Newser
Should you wait for a breakout in GH Research PLCMarket Activity Recap & Daily Stock Trend Watchlist - Newser
Real time social sentiment graph for GH Research PLCQuarterly Profit Report & AI Driven Price Forecasts - Newser
GH Research PLC stock volume spike explainedWeekly Risk Summary & Reliable Intraday Trade Alerts - Newser
How sentiment analysis helps forecast GH Research PLC2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser
Published on: 2025-09-09 00:06:21 - beatles.ru
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):